Monique Marelis

No más puestos en curso

Consumer Services

Commercial Services

Perfil

Monique Marelis worked as the Director of Human Resources at Amsterdam Molecular Therapeutics (AMT) Holding NV from 2010 to 2013.
Prior to that, she worked as a Manager of Human Resources at Dell BV.
She holds a Master's degree in Business Administration from Kingston University.

Antiguos cargos conocidos de Monique Marelis.

Empresas	Cargo	Fin
Amsterdam Molecular Therapeutics (AMT) Holding NV Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands.	Oficial de Recursos Humanos	11/03/2013
Dell BV	Oficial de Recursos Humanos	-

Ver el detalle de la experiencia de Monique Marelis.

Formación de Monique Marelis.

Kingston University

Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Monique Marelis.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Amsterdam Molecular Therapeutics (AMT) Holding NV Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands.	Commercial Services
Dell BV